Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

about

Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches.Draft Genome Sequence of a Multidrug-Resistant Pseudomonas aeruginosa Strain Isolated from a Patient with a Urinary Tract Infection in Khartoum, Sudan.

P2860

Q39062989-441FA563-FAB5-4362-9A05-94AE815DB609 Q40243230-A52C78DA-6FDD-4FB6-ADBC-ECBFCAB202DA

P2860

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

Item

http://www.wikidata.org/entity/Q41838771

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

@en

type

Item

label

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

@en

prefLabel

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

@en

P1476

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

@en

P2093

Abida Malik

http://www.w3.org/2001/XMLSchema#string

Fatima Khan

http://www.w3.org/2001/XMLSchema#string

Hiba Sami

http://www.w3.org/2001/XMLSchema#string

Indu Shukla

http://www.w3.org/2001/XMLSchema#string

Junaid Ahmad

http://www.w3.org/2001/XMLSchema#string

Meher Rizvi

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.

CDC definitions for nosocomial infections, 1988

Epidemiology of infections due to Pseudomonas aeruginosa.

In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.

Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4066/AMJ.2015.2096

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25848402

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

4321197

http://www.w3.org/2001/XMLSchema#string

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

about

P2860

P2860

Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932